panitumumab
amgen,takeda
['paradigm']
what a fantastic discussion of the paradigm trial by at the #asco22 plenary session. paradigm shift? below dr. cremolini s algorithm, agree! 
Medical Oncologist, GI cancers @nki_nl neoadjuvant #immunotherapy #cancerresearch. Opinions my own